As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan 2022-2026 and acknowledging the important role of ICH E6 as the global regulatory guideline for GCP, a multi-stakeholder workshop on ICH E6 R3 public consultation was organised by ACT EU Priority Action 4 (PA4).

If you weren’t able to participate in the workshop, a recording is available here.